Publications by authors named "Federica Coletti"
Article Synopsis
- Athletes often show changes in their electrocardiograms (ECGs) due to heart adaptations from regular training, known as the athlete's heart, but these changes can sometimes mimic heart disease signs.
- Misdiagnosis can lead to serious consequences, including sudden cardiac death, which is a major risk for young athletes.
- This review aims to help cardiologists and sports doctors differentiate between normal exercise-related ECG changes and those indicating potential heart problems, guiding further investigations when needed.
As the general population ages, the incidence of degenerative mitral stenosis (MS) among patients has increased. Percutaneous mitral valvuloplasty (PMV) has emerged as a well-established option for mitral rheumatic stenosis with specific characteristics. However, a blank therapeutic space must be filled with the treatment options for degenerative or rheumatic mitral stenosis in patients with many comorbidities and contraindication for valvuloplasty.
View Article and Find Full Text PDFArticle Synopsis
- Athletes often face interruptions in training due to injuries, such as a knee injury, and advanced testing methods like echocardiography and cardiopulmonary exercise testing (CPET) can help evaluate their heart and lung functions during recovery.
- The study involved 28 non-professional athletes with knee issues undergoing pre-surgery assessments, measuring factors like heart strain and oxygen consumption, revealing specific correlations between their physical activity and cardiac efficiency.
- Despite being less active due to injury, athletes can still achieve maximal CPET results; however, decreased heart and lung performance may contribute to, or result from, their injuries, indicating a need for careful functional evaluation before surgery.
Dyslipidemia is the most frequent cardiovascular (CV) risk factor in able-bodied athletes and is frequently undertreated, resulting in an underestimated risk of atherosclerosis-related diseases. Data on lipid profile in Paralympic athletes are lacking. Our study aimed to identify the prevalence of dyslipidemia and the influence of disability type and sporting discipline in Paralympic athletes.
View Article and Find Full Text PDFArticle Synopsis
- Coronary chronic total occlusions (CTOs) are common challenges in percutaneous coronary interventions (PCI), making them a significant focus in clinical settings.
- Despite mixed results from randomized trials on the benefits of recanalizing CTOs, the number of these procedures has notably increased due to advancements in techniques and training.
- This review aims to summarize the clinical outcomes, technical aspects, and safety concerns related to CTO revascularization to assist clinicians in their daily cath-lab practices.
Atherosclerosis is the leading cause of death worldwide, especially in patients with type 2 diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated to play a markedly protective role for the cardiovascular system beyond their glycemic control. Several cardiovascular outcome trials (CVOT) reported the association between using these agents and a significant reduction in cardiovascular events in patients with T2D and a high cardiovascular risk profile.
View Article and Find Full Text PDFArticle Synopsis
- Regular training in athletes leads to important cardiovascular changes that improve oxygen delivery during exercise.
- Cardiopulmonary exercise testing (CPET) is a key method for assessing athletic performance, offering detailed insights into cardiovascular responses and efficiency.
- This review discusses how CPET can differentiate normal athlete adaptations from potential early signs of cardiomyopathy, helping to identify health risks in competitive athletes.
Article Synopsis
- Coronary artery disease (CAD) is a major global health issue, and revascularization via percutaneous coronary interventions (PCI) can improve patient survival rates.
- Poor glycaemic control is linked to higher complications and worse outcomes during and after these procedures, regardless of whether the patient has diabetes.
- New antidiabetic medications are changing how we treat diabetes in patients with cardiovascular issues, but there is a lack of extensive research on their effects during PCI; this review explores their mechanisms, current evidence, and interactions with antiplatelet drugs.